Vitronectin (VN) and pro-urokinase (pro-uPA) stimulated migration of rat smooth muscle cells in a dosedependent and additive way, and induced motile-type changes in cell morphology together with a complete reorganization of the actin ®laments and of the microtubules. All these eects were inhibited by pertussis toxin, or by antibodies directed against the urokinase receptor (uPAR) or against the VN receptor a v b 3 suggesting that an association between the two receptors is required to mediate both signals. Investigation of the signaling pathways showed that increasing the intracellular cAMP resulted in a selective inhibition of VNinduced cell migration. On the other hand, PD 98059, an inhibitor of MEK, dierentially inhibited the pro-uPAbut not the VN-induced cell migration. Phosphorylation and nuclear translocation of Erk by pro-uPA was directly observed. We conclude that the signaling pathways of pro-uPA and VN must be at least in part dierent. Oncogene (2001Oncogene ( ) 20, 2032Oncogene ( ± 2043 
Introduction
The interaction of the urokinase receptor (uPAR) with integrins plays a major role in the regulation of cell adhesion and is most likely also involved in cell migration (Blasi, 1997; Chapman, 1997) . UPAR is a glycosylphosphatidylinositol(GPI)-anchored protein with three extracellular and no intracellular domain. UPA preferentially binds to domain 1, but all three domains are required for high anity binding. UPAR also binds vitronectin (VN) and again all three domains are required for high anity binding (Behrendt et al., 1991; Wei et al., 1994; Waltz and Chapman, 1994; Ploug et al., 1994; Kanse et al., 1996; Hùyer-Hansen et al., 1997; Sidenius and Blasi, 2000) .
UPAR is capable of complex signaling aecting not only cell adhesion, but also cell proliferation and migration (Resnati et al., 1996; Fazioli et al., 1997; Aguirre Ghiso et al., 1999; Degryse et al., 1999;  reviewed in Ossowski and Aguirre Ghiso, 2000) . Migration responses are generally observed at low (physiological) levels of uPAR expression, while proliferation responses may require higher levels as observed in cancer cells (Aguirre Ghiso et al., 1999; Ossowski and Aguirre Ghiso, 2000; Webb et al., 2000) . Several signal transducing molecules have been identi®ed (Konakova et al., 1998; Webb et al., 2000; Degryse et al., 1999; Dumler et al., 1999) .
Integrins constitute a large family of cell membrane receptors for extracellular matrix proteins and regulate cell adhesion and migration (Clyman et al., 1992; Preissner and Seiert, 1998; Byzova et al., 1998; Slepian et al., 1998) . VN is a substrate (ligand) for four integrin receptors, a v b 1 , a v b 3 , a v b 5 and a IIb b 3 . Of these, a v b 3 is of special interest in the present case, because it is present in RSMC, promotes cell migration and associates with uPAR (Brown et al., 1994; Choi et al., 1994; Bilato et al., 1997; Xue et al., 1997; Preissner and Seiert, 1998; Byzova et al., 1998) . VN can connect the uPA/uPAR and the integrin systems as it can bind to both uPAR and the integrins. The somatomedin-B domain at the N-terminus, also required for binding and stabilization of plasminogen activator inhibitor type-1, PAI-1, is required for the interaction with uPAR (Deng et al., 1996) . The interaction of VN with uPAR and PAI-1 are therefore mutually exclusive. Likewise, the interactions of VN with PAI-1 and integrins are also mutually exclusive (Stefansson and Lawrence, 1996; Kjùller et al., 1997) . Finally, cell-and extracellular matrix-bound VN can bind uPA/soluble uPAR complexes (Chavakis et al., 1998) .
The activity of several cells, rat smooth muscle cells (RSMC) among others, is tightly connected with uPAR and integrins. Smooth muscle cells are responsible for intimal hyperplasia associated with restenosis, express uPAR, uPA and a v integrins, and in vitro migrate in response to pro-uPA/uPAR (Degryse et al., 1999) .
Interactions between uPAR and integrins has been demonstrated in a variety of examples (Bohuslav et al., 1995; Wei et al., 1996; Yebra et al., 1996; Carriero et al., 1999) . A speci®c direct uPAR-binding sequence has been identi®ed in the a4 chain subunit of integrins (Simon et al., 2000) . Pro-uPA was found to induce a uPAR-dependent migration of RSMC and relocation of uPAR, a v b 3 and b 1 integrins to the leading edge (Degryse et al., 1999) . Interestingly, antibodies against a v b 3 were found to inhibit pro-uPA-induced migration (Degryse et al., 1999) suggesting an interaction between uPAR and a v b 3 . Interaction between uPAR and a v b 3 was indicated by previous data showing that VN enhances colocalization of uPA and a v b 3 to focal contacts (Ciambrone and McKeown-Longo, 1992) .
On the basis of the observations described above, pro-uPA and VN might promote (or rely upon) a direct interaction between uPAR and integrins and modulate their function. In this paper, we show that the eects of VN and pro-uPA on cell migration are additive, that both induce cytoskeleton and microtubule reorganization, and focal contact redistribution. We also show that although functional cross-talks exist between uPAR and a v b 3 , the signaling pathways dier since VN-and pro-uPA-induced cytoskeleton reorganization and migration display dierent sensitivities to protein kinase C (PK-C), phosphatidylinositol-3 kinase (PI-3K) and MEK inhibitors. In addition, cAMP levels also appeared to aect dierentially pro-uPA and VNdependent signaling.
Results

VN and pro-uPA have additive effects on RSMC migration
Pro-uPA has chemotactic activity on RSMC with a maximum at 10 nM (Degryse et al., 1999) . The activity of pro-uPA is exerted through the exposure of a uPAR chemotactic epitope located between domain D1 and D2 (Resnati et al., 1996; Fazioli et al., 1997) . Indeed, peptides covering this region have a very potent activity which is conserved in uPAR molecules of dierent species (Fazioli et al., 1997; Degryse et al., 1999 and unpublished data) . These peptides mimic in every aspect so far identi®ed, the eects of uPA, prouPA and ATF. In this paper we show that both prouPA and a chemotactic rat uPAR epitope (peptide D) cooperated with VN in chemotaxis.
Like pro-uPA, VN induced chemotaxis in RSMC with a maximum at 1 mg/ml (Figure 1a ). Pro-uPA and VN cooperated in this respect since when optimal concentrations of both pro-uPA and VN were included in the lower well of the Boyden chamber, an eect close to additive was observed (Figure 1b) . Some variability of chemotactic eect of VN and pro-uPA was observed which depended on the age of the culture. However, the eect has been repeatedly reproduced with various batches of cells.
The pentapeptide RGPRY (peptide D, from rat uPAR) is very active in RSMC both in chemotaxis and in monolayer wounding assays (Degryse et al., 1999) .
Like pro-uPA, peptide D cooperated with VN having an additive eect both in chemotaxis (not shown) and in an in vitro monolayer-wounding assay. As shown in Figure 1c , 1 mg/ml VN stimulated migration of RSMC into the wound by 50%, an eect matched by 1 pM peptide D. A better response was obtained combining both VN and peptide D (Figure 1c ). We also found that VN chemotaxis was inhibited not only by antiavb3 antibodies, but also by anti-uPAR antibodies (Table 1 ). The data of Table 1 also con®rmed that antiavb3 antibodies inhibit pro-uPA stimulation of chemotaxis as previously published (Degryse et al., 1999) and suggested some kind of association between uPAR and avb3 integrin in RSMC. This is not surprising since interactions of uPAR with integrins have been observed in several cell types (Bohuslav et al., 1995; Wei et al., 1996; Yebra et al., 1996; Xue et al., 1997; May et al., 1998; Chavakis et al., 1998; Carriero et al., 1999; Simon et al., 2000) . Direct interactions between uPAR and avb3 has also been reported (Tarui et al., 2000) . Thus VN and pro-uPA chemotactic activity appear to be linked mechanistically already at the level of their receptors.
However, the fact that pro-uPA (and uPAR peptide D) increased the stimulation of cell migration obtained with VN suggested that the two inducers act through an at least partly dierent signaling pathway.
VN, like pro-uPA, induces cell shape changes and cytoskeleton reorganization Pro-uPA induces a major cytoskeletal change in RSMC (Degryse et al., 1999) . We have tested the eect of VN on cytoskeletal actin organization (by phalloidin¯uorescence) and on the structure of the focal contacts (immuno¯uorescence with vinculinspeci®c antibodies) (Figure 2a) . In control cultures, most RSMC exhibited numerous stress ®bers and a diuse pattern of vinculin-stained focal contacts. After 30 min of stimulation with 1 mg/ml VN, RSMC assumed a more polarized shape typical of motile cells. Membrane ruing and semi-ring structures of actin were observed at the leading edge of the cell. Vinculin was redistributed in an approximately double-row pattern on each side of the actin semi-ring and at the end of actin ®laments present in the dragging side. As also shown in Figure 2a , these eects were very similar to those observed with pro-uPA and previously reported (Degryse et al., 1999) . Quantitation of these experiments by counting the per cent of cells displaying reorganization of the actin cytoskeleton showed that, as previously published for pro-uPA (Degryse et al., 1999) , VN doubled the per cent of cells that assumed a motile phenotype (data not shown).
We also tested the eects of VN and pro-uPA on the microtubules network by immuno¯uorescence with anti-b-tubulin antibodies. As shown in Figure 2b , microtubules of unstimulated RSMC formed a network which surrounded the nucleus and evenly covered the entire cytoplasm. VN, more than pro-uPA, redistributed the microtubule network increasing its density at the trailing side of the cell and decreasing it at the leading edge from where the microtubules radiated to reach the nucleus or follow the periphery of the cell ( Figure 2b ). As shown in Figure 2c , in some VN-treated cells microtubules and actin ®laments were organized both around the nucleus, as in resting RSMC, and at the two extremities, as in migrating RSMC.
Cytoskeletal changes were also observed in a wounded RSMC monolayer stimulated with VN or peptide D. As shown in Figure 2d , the RSMC that migrated into the wound following stimulation with VN or peptide D showed an elongated polarized morphology and cytoskeleton reorganization. Overall these results show that VN aects cytoskeletal and microtubule organization, in a way similar to pro-uPA.
Effects of antibodies against uPAR and a v b 3 on cytoskeleton reorganization
Pro-uPA-induced migration and cytoskeletal organization in RSMC were shown to be functionally interdependent (Degryse et al., 1999) . To test whether the Optimal doses of VN (1 mg/ml) and pro-uPA (10 nM) exert additive eects. VN, pro-uPA or both were present only in the lower well. (c) VN and the chemotactic uPAR linker-region-peptide D have additive eects in a monolayer wounding assay. The wounding assay is described in the Materials and methods section. The ordinates (cell migration) represents the number of RSMC migrating into the wound in the presence of stimulants, expressed in per cent, compared to non-stimulated cells (set to 100%). The data represent the average of two experiments carried out in triplicate and were collected by counting a total of ®ve representative areas of the wound. Peptide D (1 pM) is the rat minimal chemotactic peptide (10) with the sequence PRGRY observed cytoskeletal reorganization and cell migration were connected also in the case of VN, we employed the same antibodies which inhibited cell migration (see Table 1 ) on pro-uPA and VN-induced cytoskeleton changes. As shown in Figure 3 , when antibodies against a v b 3 or uPAR were present during the treatment of RSMC with VN and pro-uPA, the eects on shape change and cytoskeletal reorganization of *Chemotaxis assays were carried out in Boyden chambers (see the Materials and methods section). RSMC migrated towards medium alone (no addition) 1 mg/ml VN, 10 nM pro-uPA or 10 77 M fMLP without or with the addition of antibodies as indicated above. Cells were pre-treated for 1 h at 48C in serum-free medium without or with antibodies anti-a v b 3 (LM 609) (0.5 mg/ml) or with antibodies against u-PAR (10 mg/ml) or with unspeci®c isotype-matched control antibodies (10 mg/ml). Then, cells were subjected to chemotaxis assay. Antibodies at the same concentrations as in the pretreatment were added in both chambers of Boyden apparatus and present during the whole assay. 20 000 ± 40 000 cells per well in serum-free DMEM cells were allowed to migrate. Random cell migration of RSMC towards medium alone without any chemoattractants nor antibodies was considered to be 100% migration. The data are expressed in per cent of control+s.d. Organization of actin ®laments in RSMC migrating into a wounded monolayer. FITC-Phalloidin¯uorescence was carried out on a wounded RSMC monolayer without additions (Control) or 24 h after the addition of 1 mg/ml VN, 10 nM pro-uPA or a combination of peptide D (1 pM) plus VN (1 mg/ml). (e) Pertussis Toxin (PT) inhibits VN-induced actin cytoskeleton reorganization. RSMC, were pretreated either with 50 ng/ml PT or with mutated PT for 6 h, and then stimulated with 1 mg/ml VN for 30 min at 378C. Control: RSMC immediately after the addition of VN. The photographs show FITC-phalloidin-¯uorescence RSMC were totally inhibited. The antibodies had no in¯uence on the shape of unstimulated RSMC. The isotype-matched control antibodies did not exert any eect. Therefore, also the eects of VN on cell shape may require some kind of interaction of a v b 3 with uPAR.
The effects of VN and pro-uPA are Pertussis Toxin-sensitive
We have previously reported that pro-uPA (or the chemotactic uPAR linker region-peptide) induced chemotaxis and activated the intracellular Hck tyrosine kinase (Resnati et al., 1996; Fazioli et al., 1997) . Chemotaxis was blocked by inhibitors of tyrosine kinases. In addition, pertussis toxin (PT) also inhibited both chemotaxis and Hck phosphorylation (Fazioli et al. 1997) . As shown in Table 2 , PT (50 ng/ml) inhibited VN as well as pro-uPA chemotactic eects. The control fMLP, a formylated chemotactic peptide, the activity of which is mediated by the G-protein coupled receptor FPR-1 (Boulay et al., 1990) , was also blocked by PT. Mutated PT, which does not ADP-ribosylate G proteins, had no eect. Random cell migration was not altered by the toxin. This result suggests that the chemotactic eects of pro-uPA and VN are mediated by a G-protein coupled receptor, just like for fMLP.
As for pro-uPA (Degryse et al., 1999) , PT (50 ng/ml) also blocked VN-induced cytoskeleton reorganization while mutated PT did not (Figure 2e ). The toxins did not exert any eect on unstimulated RSMC. Thus also in this respect VN-and pro-uPA-induced migration was similar, suggesting that their eects could be mediated by a G-protein coupled receptor.
Pro-uPA/uPAR, but not VN/a v b 3 , stimulates cell migration through activation of MAP kinase
We have analysed the role of downstream signaling eectors in pro-uPA vs VN-dependent chemotaxis. In these experiments, the cells were pretreated with the inhibitors (see Materials and methods section) and then subjected to chemotaxis assays, immunoprecipitation or immuno¯uorescence. During migration, the inhibitors were present in both the upper and lower well of the Boyden chamber, as opposed to the chemoattractants which were present only in the lower well. As shown in Table 3 , PK-C inhibitor staurosporine Figure 3 Antibodies against either a v b 3 or uPAR can inhibit VN-as well as pro-uPA-induced cytoskeletal reorganization. RSMC were pretreated overnight without or with either monoclonal anti-a v b 3 (0.5 mg/ml), polyclonal anti-uPAR (10 mg/ml) or control (polyclonal or monoclonal) antibodies (10 mg/ml), as indicated (see Materials and methods). RSMC were stimulated for 30 min with either 1 mg/ml VN or 1 nM pro-uPA as indicated and analysed by FITC-phalloidin¯uorescence (see Materials and methods section). The antibodies used during the pre-treatment were present also during the stimulation period (0.7 nM) inhibited both pro-uPA-and VN-dependent eects, although VN appeared less sensitive. The other inhibitor H7 (6 mM) also strongly reduced (but not abolished) pro-uPA migration and even less VN migration. Wortmannin (50 nM), a speci®c inhibitor of PI-3 kinase which binds covalently to the p110 subunit and inhibits at nanomolar concentrations (Kapeller and Cantley, 1994) , blocked pro-uPAchemotaxis while only reducing VN-dependent migration (Table 3) . At 1 mM, wortmannin totally blocked also VN-dependent migration; at this concentration, however, the inhibitor may not be speci®c. LY 294002, a less speci®c inhibitor of PI-3K, inhibited both prouPA and VN pathways although again the inhibition was not complete in the case of VN. The results with PK-C and PI-3-Kinase inhibitors are thus not very informative.
A clear dierence among pro-uPA and VN was observed when the cells were treated with cAMPincreasing regimens, or with an inhibitor of Mek1/2 (Table 3) . A combination of IBMX and forskolin had no eect on pro-uPA, but totally inhibited VNdependent migration. Thus PK-A may be a negative regulator of the VN-dependent pathway. On the other hand, treatment of the cells with PD 98059, an inhibitor of MEK/MAPKK which prevents activation of Erk, completely blocked pro-uPA-induced migration without aecting VN-dependent chemotaxis. In view of the additivity of pro-uPA and VN eects, we have tested PD 98059 on VN-plus-pro-uPA-induced chemotaxis. As shown in Figure 4 , in the presence of PD 98059 pro-uPA and VN eects were no longer additive. Quantitatively the results are compatible with PD 98059 inhibiting only the pro-uPA-stimulated fraction of cell migration.
We have also tested the above inhibitors on actin reorganization induced by pro-uPA or VN, by TRITCphalloidin¯uorescence. Cells were treated with VN or pro-uPA for 30 min in the presence or absence of the inhibitors and phalloidin¯uorescence recorded. As shown in Table 4 , staurosporine (0.7 nM) or wortmannin (50 nM) decreased profoundly the number of cells exhibiting a modi®ed cytoskeleton upon pro-uPA and Table 1 . Cells were pretreated with the indicated inhibitors for 6 h prior to the assay, except in the case of PD 98059 (1 h). During the assay, the inhibitors were present both in the lower and in the upper chamber. 15 000/20 000 cells were allowed to migrate per well. Random cell migration of RSMC towards medium alone without any chemoattractants nor antibodies was considered to be 100% migration. The data are expressed in per cent of control+s.d. Figure 4 The MEK inhibitor PD 98059 blocks pro-uPA-induced migration and inhibits in part the VN+pro-uPA-induced migration. Chemotaxis assays were carried out as described in the Materials and methods section and in the legend of Figure 1 . Chemoattractants were present only in the lower well. Unstimulated cell migration is arbitrarily given the value of 100%
Oncogene Different pathways for urokinase and vitronectin chemotaxis B Degryse et al VN addition, but did not aect unstimulated RSMC. The increase of intracellular cAMP induced cell retraction, and addition of pro-uPA or VN did not overcome this morphological change (data not shown). Cyclic AMP has a well-known eect on cytoskeletonreorganization that results in arborized or stellate shape (Graves and Lawrence, 1996; Howe and Juliano, 2000) . The eect of IBMX plus forskolin on pro-uPA induced cytoskeleton rearrangements does not agree with the lack of eect of the increase in cAMP level on pro-uPA induced chemotaxis. Finally, as in chemotaxis assays, 50 mM of the MAP-K inhibitor PD 98059 blocked the pro-uPA-induced but had no eect on VNdependent reorganization of actin cytoskeleton (Table  4 ). Figure 5 qualitatively shows some of the eects observed.
The results of the experiments with the signaling inhibitors essentially con®rm that at least the phosphorylation of Erk is required for chemotaxis and cytoskeleton organization induced by pro-uPA in RSMC . We have therefore directly studied some aspects of the signaling pathway induced by pro-uPA. Immuno¯uorescence with anti-Raf antibodies revealed that in unstimulated RSMC, c-Raf-1 was present mainly in the cytoplasm; however, treatment of cells with pro-uPA induced its membrane association (not shown). The same eect was observed with the chemotactic uPAR peptide D (1 pM) and the Figure 6a . A transient translocation of c-Raf to the plasma membrane and at sites of cell ± cell contacts occurred within the ®rst 5 min of treatment. After 30 min, cRaf-1 was still observed mainly at the leading edge of the cells. The eect was transient and after 120 min cRaf-1 was again in the cytoplasm. The kinetics of the eect is very similar to the changes in cytoskeleton induced by pro-uPA or peptide-D, that also return to normal within 2 h (Degryse et al., 1999) . Since activation of c-Raf directly leads to activation of the MAP kinases pathway, we have studied the eect of pro-uPA and VN on Erk phosphorylation and intracellular localization. Using Erk-speci®c antibodies, we observed that a treatment for 30 min with pro-uPA (1 nM) induced the nuclear localization of Erk in RSMC. The eect was blocked by PD 98059. In contrast, VN (1 mg/ml) did not induce the translocation of the MAP kinase and consequently the addition of PD 98059 had no eect (Figure 6b ). The same result was obtained with peptide D (data not shown). As shown in Figure 6c , the peptide D (1 pM) induced Erk phosphorylation, as shown by immuno-precipitation with speci®c antibodies and blotting with antibodies recognizing phosphorylated Erk. In this case, a peak of activity was observed at 10 ± 15 min, without any signi®cant change in the total MAP kinase protein.
Pro-uPA did the same (not shown), as expected from previous studies .
Discussion
Pro-uPA and VN are ligands for well known cell surface receptors, uPAR and a v b 3 integrin, respectively. In addition to their direct involvement in the proteolytic (uPAR) and adhesive properties of cells, both pro-uPA (Gudewicz and Bilboa, 1987; Boyle et Fibbi et al., 1988; Del Rosso et al., 1992; Resnati et al., 1996; Gyetko et al., 1996; Degryse et al., 1999) and VN (Yebra et al., 1996; Kjùller et al., 1997; Stahl and Mueller, 1997; Carriero et al., 1999; directly stimulate cell migration. The interaction of uPAR with several integrins and the modulation of their function is an established fact; for example, the presence and the level of uPAR aects the choice between adhesion on ®bronectin v. vitronectin, the internalization of ®brinogen or even the constitutive activation of MAP-K in certain cancer cells leading to cell proliferation Simon et al., 1996; Xue et al., 1997; Dumler et al., 1999; Aguirre Ghiso et al., 1999; Kusch et al., 2000) . Direct interactions of uPAR with integrins has been shown by several techniques, including¯uorescence resonance energy transfer and co-immuno-precipitation (Bohuslav et al., 1995; Wei et al., 1996; Yebra et al., 1996; Xue et al., 1997; Carriero et al., 1999 Simon et al., 2000 . Speci®cally, association of uPAR with a v b 3 -expressing cells has also been reported (Tarui et al., 2000) . Indeed, in leukocytes uPA regulates co-localization of b2-integrins and uPAR (Xue et al., 1997) , in RSMC pro-uPA induces the co-localization of uPAR and a v b 3 to the rues of the plasma membrane (Degryse et al., 1999) , while in ®broblasts adhesion on VN induces colocalization of uPAR and a v b 3 (Ciambrone and McKeown-Longo, 1992) .
In this paper a comparison of the pro-uPA and VN eects on chemotaxis has revealed that pro-uPA and VN signaling pathways have some initial steps in common but subsequently dier. Through as yet unde®ned cell surface interaction, uPAR and a v b 3 receptors both rely on the interaction with a PTsensitive receptor, possibly of the G protein-coupled receptor type, to induce cell migration. However, several subsequent steps appear to be quite dierent and explain the additivity of the eects of the two inducers.
Pro-uPA and VN effects are additive
In RSMC both pro-uPA-and VN-induced chemotaxis involve an as yet unde®ned interaction between uPAR and a v b 3 , since both could be inhibited by antibodies directed at either of them (Table 1 ). In fact, the eect of VN was potentiated in cells which overexpressed uPAR (Degryse et al., unpublished) . This is similar to previous results showing that a v b 5 -dependent stimulation of migration required uPAR (Yebra et al., 1996; Carriero et al., 1999) .
In RSMC, VN exerted its maximal eect at 1 mg/ ml (Figure 1a ) similar to that of 10 nM pro-uPA. However, the combination of pro-uPA (10 nM) plus VN (1 mg/ml) led to a further increase of migration (Figure 1b) . Thus the machinery that regulates cell migration was not at its maximum under the conditions when VN or pro-uPA stimulated maximally. This result was not limited to RSMC as it was also observed with LB6 clone 19, mouse tumor cells expressing human uPAR (Degryse and Blasi, unpublished) . The failure of one single chemoattractant to give a maximal migratory response suggests that cells can respond to more than one chemotactic gradient activating independent pathways. Thus even if uPAR and a v b 3 interact at the cell surface, dierent signals must be sent intracellularly by the two attractants.
Another similarity between pro-uPA and VN is that VN induced also changes in cell shape, cytoskeleton and microtubules reorganization (Figure 2 ), in addition to chemotaxis. These changes were more pronounced in the case of VN.
The ®nal similarity is the PT sensitivity of the chemotactic activities of both pro-uPA and VN (Table 2) , which suggests the involvement of a PTsensitive mediator, possibly an heterotrimeric G protein-coupled receptor. Likewise, PT inhibited the cytoskeletal changes induced by both pro-uPA and VN (Figure 2e ). Interestingly, PT inhibited not only the pro-uPA-induced changes, but also those obtained with the rat uPAR chemotactic epitope, peptide D. As previously published (Resnati et al., 1996; Degryse et al., 1999 ) the chemotactic uPAR peptides appear to act through the same pathway as uPA.
VN and pro-uPA activate different signaling pathways
Despite the several similarities between the eects of the two inducers, VN-and pro-uPA-induced chemotaxis proved to be dierentially sensitive to inhibitors of some signaling eectors. When assayed in Boyden chambers, pre-treatment with IBMX and forskolin speci®cally inhibited the chemotactic response to VN but not to pro-uPA (Table 3) . IBMX and forskolin increase cellular cAMP level and hence activate PK-A. Thus the eect of IBMX-forskolin suggests that PK-A might be a negative modulator of the VN-induced signaling pathway. The increase in cAMP is known to disrupt the cytoskeleton (Schoenwaelder and Burridge, 1999) . In fact while activation of the MAP-K is anchorage-dependent (Miyamoto et al., 1996; Lin et al., 1997 Renshaw et al., 1997 , it can be inhibited in adherent cells by increasing cAMP (Graves and Lawrence, 1996) .
The dierential sensitivity of pro-uPA and VNchemotaxis are in agreement with the inability of VN to induce Erk activation (Figure 6 ). These dierences are furthermore highlighted by the eect of the MEK inhibitor PD 98059. In this case, only pro-uPAdependent migration was blocked. The stimulation of ERK phosphorylation and nuclear translocation by pro-uPA has been reported by others (Konakova et al., 1998; Nguyen et al., 1998 Nguyen et al., , 1999 Nguyen et al., , 2000 Webb et al., 2000) . We con®rm these observations in RSMC (Figures 6 and 7) . Peptide D (like pro-uPA) also induced the relocation to the cell surface of the upstream MEK activator, c-Raf-1 (Figure 6a ). PD 98059 inhibited not only the pro-uPA-induced ERK nuclear translocation (Figure 6 ) but also chemotaxis (Table 3 ) and cytoskeletal changes (Figure 4) . How-ever, PD 98059 had no eect on these same processes when they were induced by VN.
Another dierence between pro-uPA and VN was scored with respect to the sensitivity to protein kinase-C and PI-3 kinase inhibitors. Wortmannin and LY294002 inhibited pro-uPA chemotaxis at low concentrations while VN-induced chemotaxis required higher concentrations, at which the inhibitor may not be speci®c. A similar eect was observed with the PK-C inhibitor staurosporine (Table 3) . Wortmannin and staurosporine, however, inhibited also the cytoskeletal changes induced by pro-uPA as well as by VN. Possibly, the recording of the phalloidin¯uorescence was not sensitive enough to detect dierences of cytoskeleton organization. These data are therefore not informative enough to draw any conclusion on the role of PK-C and PI-3 kinase in pro-uPA vs VNinduced chemotaxis.
In conclusion, our data suggest that the chemotactic response to both pro-uPA and VN might involve both uPAR and a v b 3 , possibly through a cell-surface association. We do not know whether it is a direct interaction nor whether the interaction is constitutive or induced by the addition of pro-uPA or VN. However, c-Src, integrins and uPAR were shown to translocate to the leading edge, following treatment of RSMC with pro-uPA (Degryse et al., 1999) . It was also previously shown that tyrosine kinases of the Src family, like Hck and Fak, undergo phosphorylation with pro-uPA, that pro-uPA stimulation of chemotaxis was inhibited by tyrosine kinase inhibitors and did not occur in ®broblasts from Src-de®cient mice (Resnati et al., 1996; Fazioli et al., 1997; Degryse et al., 1999; Nguyen et al., 1999) . Downstream phosphorylation and nuclear translocation of Erk is also required. We now report that treatment of RSMC with pro-uPA also induces c-Raf translocation to the membrane (Figure 6a ), an indication of its activation. Moreover, the results also indicate that PK-C and PI-3 kinase may be implicated in pro-uPA-stimulated migration.
We also report here that PT inhibits chemotaxis and cytoskeleton rearrangements induced by both pro-uPA and VN. The PT-sensitive molecule may be a Gprotein coupled receptor possibly acting immediately after the uPAR/a v b 3 interaction. This would be in agreement with the fact that PT acts on a very early step of the pathway, as shown by the inhibition not only of the chemotaxis but also of Hck phosphorylation (Fazioli et al., 1997) . The molecule responsible for the PT sensitivity of pro-uPA has not yet been identi®ed, but de-sensitization experiments indicate that it might be a known chemotactic receptor (M Resnati and F Blasi, in preparation) .
Materials and methods
Materials and cell culture
Rat aortic smooth muscle cells (RSMC), a kind gift of Dr M Bertulli (Bayer Research Laboratories, Milano, Italy) were cultured in DMEM plus 10% FCS. Bordetella pertussis toxin (PT) and its mutant were a kind gift of Dr MG Pizza (Siena, Italy). The antibodies used were: mouse monoclonal antivinculin, anti-b tubulin (Sigma), anti-ERK (New England Biolabs), anti-a v b 3 (LM 609, Chemicon) and rabbit polyclonal anti-c-Raf-1 (Santa Cruz Biotechnology). The secondary antibodies were TRITC-and FITC-F(ab)'2 fragments of anti-rabbit and anti-mouse immunoglobulins (Boehringer Mannheim). Non-speci®c rabbit polyclonal immunoglobulins, non-speci®c mouse monoclonal IgG1k (MOPC-21), TRITCand FITC-phalloidin were from Sigma. Peptide D, PRGRY, is the rat equivalent of the human SRSRY uPAR peptide which reproduces the pro-uPA chemotactic eects in rat cells (Degryse et al., 1999; Resnati et al., 1996) . Rat pro-uPA and anti-rat uPAR antibody were described previously (Degryse et al., 1999) . VN was puri®ed from human plasma (Yatohgo et al., 1988) . Highly puri®ed RAP was kindly donated by Dr Morten Nielsen (Department of Medical Biochemistry, University of A Ê arhus, Denmark).
Immunopurification of uPA/PAI-1 complexes
Recombinant PAI-1 was puri®ed from E. coli strain BL21[DE3]pLysS transformed with a His-tagged PAI-1 construct (pPAI-HIS), kindly supplied by Drs HM Tucker and R Gerard (Dallas, TX, USA). r-PAI-1 was extracted using lysozyme (0.5 mg/ml) and puri®ed with nickel agarose resin (Qiagen) and a heparin Sepharose CL-6B column, eluted with 1 M NaCl, 10% glycerol, 50 mM Na 2 HPO 4 , pH 6.0 and dialyzed overnight against PBS. Complexes of uPA and r-PAI-1 were formed as described (Conese et al., 1995) . To eliminate PAI-1 from complexes the mixture was passed on a Protein A Sepharose 4 column to which AD #394 monoclonal antibody against human urokinase had been attached. The column was equilibrated with 0.1 M Tris, 0.1 M NaCl, 0.01% Tween-20 (pH 8.1) and eluted with 0.1 M acetic acid, 1.0 M NaCl, 0.01% Tween-20. Fractions were tested on 10% SDS ± PAGE and found to be free of uncomplexed uPA or PAI-1.
Chemotaxis assay
Chemotaxis assays were performed as described (Degryse et al., 1999) with modi®ed Boyden chambers using ®lters (5 mm pore size, Corning) treated with collagen I (100 mg/ml) and ®bronectin (10 mg/ml, Boehringer Mannheim). 20 000 ± 40 000 cells in serum-free DMEM were added to the upper well and the chemoattractants tested added to the lower well. When present, antibodies, PT or inhibitors were added in both wells of Boyden chambers. After overnight migration at 378C, cells remaining on the upper surface of ®lters were scraped o and ®lters were ®xed in methanol and stained in a solution of 10% (w/v) crystal violet in 20% (v/v) methanol. The experiments were performed in triplicate and the results, expressed as fold over control, are the mean+sd of the number of cells counted in 10 high power ®elds per ®lter. Random cell migration, i.e. migration in the absence of chemoattractant, was given the arbitrary value of 100%. In some experiments, cells were pretreated either with antibodies (overnight), PT or with dierent inhibitors (6 h, except with PD 98059, New England Biolabs, 1 h). In all Figures, data representative of at least three experiments are shown.
Wounding assay
As previously described (Degryse et al., 1999) , FCS-starved RSMC were injured by single-cross wound, washed once with PBS, and were allowed to recover for 24 h in serum-free DMEM without or with 1 pM rat uPAR chemotactic peptide D. RSMC were ®xed and stained with TRITC-phalloidin as described below. Quanti®cation was made by counting the cells that had migrated into the wound.
Erk phosphorylation
Serum-starved RSMC (50 ± 70% con¯uence) were challenged with 1 pM rat chemotactic uPAR peptide D or with 10 nM pro-uPA, washed with PBS, lysed in 0.05 M tris pH 6.8, 2% SDS, 1% Triton X-100, 0.2 M Na 3 VO 4 plus protease cocktail inhibitors. One hundred mg of total proteins were electrophoresed in SDS ± PAGE, after Western blotting. Nonphosphorylated (i.e. total) and phosphorylated ERK were detected using primary antibodies (see Materials and methods) and 125 I-protein A.
Immunofluorescence microscopy
As previously described (Degryse et al., 1999) , 15 000 ± 25 000 RSMC (20 ± 40% con¯uence), were seeded on glass coverslips in 2 cm 2 well, cultured for 24 h in DMEM plus 10% FCS, washed with PBS and cultured for another 24 h without FCS. In some experiments, cells were pretreated either with antibodies (overnight), PT or with inhibitors (6 h, except with PD 98059, New England Biolabs, 1 h). After stimulation, RSMC were ®xed for 20 min at room temperature with 3% paraformaldehyde, 2% sucrose in PBS pH 7.5, washed three times with PBS-BSA 0.2%, permeabilized with 20 mM HEPES pH 7.4, 300 mM sucrose, 50 mM NaCl, 3 mM MgCl 2 , 0.5% (v/v) Triton X-100 for 3 min at 48C and washed three times with 0.2% PBS-BSA. RSMC were incubated in 2% PBS-BSA for 15 min at 378C, then with primary antibodies for 30 min at 378C, washed three times with PBS-BSA 0.2% and further incubated with PBS-BSA 2% for 15 min at 378C. Then, cells were stained with secondary antibodies, and/or with phalloidin for visualization of ®lamentous actin, for 30 min at 378C. Finally, after three washes with 0.2% PBS-BSA, one with distilled water, coverslips were mounted with 20% (w/v) Mowiol. Photographs were taken on either Kodak T-Max 400 or EPH P1600X ®lm using a Zeiss Axiophot microscope.
Abbreviations PI-3K, phosphatidylinositol-3 kinase; PK-A, protein kinase A; PK-C, protein kinase C; pro-uPA, pro-urokinase; PT, pertussis toxin; RSMC, rat smooth muscle cells; uPA, urokinase; uPAR, urokinase receptor; VN, vitronectin.
